These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 28933733)
1. Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A Hevia D; Gonzalez-Menendez P; Fernandez-Fernandez M; Cueto S; Rodriguez-Gonzalez P; Garcia-Alonso JI; Mayo JC; Sainz RM Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933733 [TBL] [Abstract][Full Text] [Related]
2. Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer. Hevia D; González-Menéndez P; Quiros-González I; Miar A; Rodríguez-García A; Tan DX; Reiter RJ; Mayo JC; Sainz RM J Pineal Res; 2015 Mar; 58(2):234-50. PubMed ID: 25612238 [TBL] [Abstract][Full Text] [Related]
3. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Siu SW; Lau KW; Tam PC; Shiu SY Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702 [TBL] [Abstract][Full Text] [Related]
4. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile. Vaz CV; Alves MG; Marques R; Moreira PI; Oliveira PF; Maia CJ; Socorro S Int J Biochem Cell Biol; 2012 Nov; 44(11):2077-84. PubMed ID: 22964025 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression. Xi SC; Siu SW; Fong SW; Shiu SY Prostate; 2001 Jan; 46(1):52-61. PubMed ID: 11170132 [TBL] [Abstract][Full Text] [Related]
6. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes. Vaz CV; Marques R; Alves MG; Oliveira PF; Cavaco JE; Maia CJ; Socorro S J Cancer Res Clin Oncol; 2016 Jan; 142(1):5-16. PubMed ID: 26048031 [TBL] [Abstract][Full Text] [Related]
7. Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells. Gonzalez-Menendez P; Hevia D; Rodriguez-Garcia A; Mayo JC; Sainz RM Endocrinology; 2014 Sep; 155(9):3238-50. PubMed ID: 24932809 [TBL] [Abstract][Full Text] [Related]
9. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Sainz RM; Mayo JC; Tan DX; León J; Manchester L; Reiter RJ Prostate; 2005 Apr; 63(1):29-43. PubMed ID: 15378522 [TBL] [Abstract][Full Text] [Related]
10. The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas? Gonzalez-Menendez P; Hevia D; Mayo JC; Sainz RM Int J Cancer; 2018 Jun; 142(12):2414-2424. PubMed ID: 29159872 [TBL] [Abstract][Full Text] [Related]
11. Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevention and therapy. Shiu SY; Leung WY; Tam CW; Liu VW; Yao KM J Pineal Res; 2013 Jan; 54(1):69-79. PubMed ID: 22856547 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative action of melatonin on human prostate cancer LNCaP cells. Moretti RM; Marelli MM; Maggi R; Dondi D; Motta M; Limonta P Oncol Rep; 2000; 7(2):347-51. PubMed ID: 10671684 [TBL] [Abstract][Full Text] [Related]
13. Melatonin Signaling Controls the Daily Rhythm in Blood Glucose Levels Independent of Peripheral Clocks. Owino S; Contreras-Alcantara S; Baba K; Tosini G PLoS One; 2016; 11(1):e0148214. PubMed ID: 26824606 [TBL] [Abstract][Full Text] [Related]
14. Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration. Rodríguez C; Puente-Moncada N; Reiter RJ; Sánchez-Sánchez AM; Herrera F; Rodríguez-Blanco J; Duarte-Olivenza C; Turos-Cabal M; Antolín I; Martín V J Cell Physiol; 2021 Jan; 236(1):27-40. PubMed ID: 32725819 [TBL] [Abstract][Full Text] [Related]
15. Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Jose C; Hebert-Chatelain E; Dias Amoedo N; Roche E; Obre E; Lacombe D; Rezvani HR; Pourquier P; Nouette-Gaulain K; Rossignol R Redox Biol; 2018 Sep; 18():33-42. PubMed ID: 29935387 [TBL] [Abstract][Full Text] [Related]
16. Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype. Shiu SY; Law IC; Lau KW; Tam PC; Yip AW; Ng WT J Pineal Res; 2003 Oct; 35(3):177-82. PubMed ID: 12932201 [TBL] [Abstract][Full Text] [Related]
17. A pairwise chemical genetic screen identifies new inhibitors of glucose transport. Ulanovskaya OA; Cui J; Kron SJ; Kozmin SA Chem Biol; 2011 Feb; 18(2):222-30. PubMed ID: 21338919 [TBL] [Abstract][Full Text] [Related]
18. A long noncoding RNA connects c-Myc to tumor metabolism. Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540 [TBL] [Abstract][Full Text] [Related]
19. Influence of melatonin receptor signalling on parameters involved in blood glucose regulation. Bazwinsky-Wutschke I; Bieseke L; Mühlbauer E; Peschke E J Pineal Res; 2014 Jan; 56(1):82-96. PubMed ID: 24117965 [TBL] [Abstract][Full Text] [Related]
20. Melatonin receptor type 1 signals to extracellular signal-regulated kinase 1 and 2 via Gi and Gs dually coupled pathways in HEK-293 cells. Chen L; He X; Zhang Y; Chen X; Lai X; Shao J; Shi Y; Zhou N Biochemistry; 2014 May; 53(17):2827-39. PubMed ID: 24724723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]